8YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Dynasore | DYNASORE | 304448-55-3 |
| (3-chloropyrazin-2-yl)methanamine hydrochloride | 3-氯吡嗪-2-甲胺二盐酸盐 | 867165-53-5 |
| Ganetespib(STA 9090) | GANETESPIB | 888216-25-9 |
| VRT752271 | 4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羟基乙基]-1H-吡咯-2-甲酰胺 | 869886-67-9 |
| RS-1 | 4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 | 312756-74-4 |
| ML216 | N-[4-氟-3-(三氟甲基)苯基]-N'-[5-(4-吡啶基)-1,3,4-噻二唑-2-基]脲 | 1430213-30-1 |
| KN-93 Phosphate | KN-93PHOSPHATE | 1188890-41-6 |
| Selonsertib | SELONSERTIB | 1448428-04-3 |
| LY 294002 HYDROCHLORIDE | LY294002/PI3K抑制剂 | 154447-36-6 |
| GSK 429286A | N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺 | 864082-47-3 |
| Ponatinib | 帕纳替尼 | 943319-70-8 |
| PIK-294 | PIK-294 | 900185-02-6 |
| ISX9 | ISX 9 | 832115-62-5 |
| BMS-687453 | BMS 687453 | 1000998-59-3 |
| KN-93 hydrochloride | 化合物 T21557 | 1956426-56-4 |
| GPR39-C3 | CS-2374 | 1621175-65-2 |
| 4-Pyridylacetonitrile Hydrochloride | 4-吡啶乙腈 | 92333-25-0 |
| H-89 | N-[2-[P-溴苯丙烯盐基氨基]乙基]-5-异喹啉磺酰胺 | 127243-85-0 |
| abt263 | ABT 263 | 923564-51-6 |
| CID755673 | 2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one | 521937-07-5 |
| NLG919 | 1-环己基-2-(5H-咪唑并[5,1-A]异吲哚-5-基)乙醇 | 1402836-58-1 |
| CPI-169 (racemate) | 化合物CPI169 | 1450655-76-1 |
| SP2509 | SP2509 | 1423715-09-6 |
| HMPL-013 | 呋喹替尼 | 1194506-26-7 |
| XY1 | N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 | 1624117-53-8 |
| M2I-1 | 312271-03-7 | 312271-03-7 |
| Sulfatinib | 索凡替尼 | 1816307-67-1 |
| IC261 | 3-(2,4,6-三甲氧基苯亚甲基)吲哚啉-2-酮 | 186611-52-9 |
| 3-Cyano-7-ethoxycoumarin | 3-氰基-7-乙氧基香豆素 | 117620-77-6 |
| KN-93 | N-[2-[N-(4-氯肉桂)-N-甲基氨基]苯基]-N-(2-羟乙基)-4-甲氧苯磺酰胺磷酸酯盐 | 139298-40-1 |
| JNJ 31020028 | JNJ 31020028 | 1094873-14-9 |
| PD0166285 | 6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 | 185039-89-8 |
| MM-102 | MM-102 | 1417329-24-8 |
| G007-LK | G007-LK | 1380672-07-0 |
| MPI-0479605 | N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 | 1246529-32-7 |
| AZD8186 | 8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 | 1627494-13-6 |
| CHS 828 | N-[6-(4-氯苯氧基)己基]-N'-氰基-N''-4-吡啶基胍 | 200484-11-3 |
| BIX-01294 | BIX 01294 | 935693-62-2 |
| OTX015 | OTX-015 | 202590-98-5 |
| JH-II-127 | JH-II-127 | 1700693-08-8 |
| Elafibranor(GFT505) | GFT505 | 923978-27-2 |
| Cardiogenol C HCl | 2-({2-[(4-甲氧基苯基)氨基]嘧啶-4-基}氨基)乙醇 | 671225-39-1 |
| Bohemine | BOHEMINE | 189232-42-6 |
| AG490 | 酪氨酸磷酸化抑制剂AG 490 | 133550-30-8 |
| Capromorelin | 卡普瑞林 | 193273-66-4 |
| PCI 34051 | N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺 | 950762-95-5 |
| Ponatinib Mono-hydrochloride | 泊那替尼盐酸盐 | 1114544-31-8 |
| ML 204 | 4-METHYL-2-(1-PIPERIDINYL)-QUINOLINE | 5465-86-1 |
| PF-06447475 | PF-06447475 | 1527473-33-1 |
| MCC950 | MCC950 | 210826-40-7 |
| SB431542 | SB-431542 | 301836-41-9 |
| PUROMYCIN AMINONUCLEOSIDE | 维生素E醋酸酯 | 58-60-6 |
| Reversine | REVERSINE | 656820-32-5 |
| SB202190 | 4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑 | 152121-30-7 |
| Scriptaid | SCRIPTAID | 287383-59-9 |
| CFTR Inhibitor II | GLYH 101 | 328541-79-3 |
| GSK369796 | GSK369796 | 1010411-21-8 |
| (5-chloropyridin-2-yl)MethanaMine dihydrochloride | (5-氯吡啶-2-基)甲胺双盐酸盐 | 1257535-54-8 |
| GKT137831 | 2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 | 1218942-37-0 |
| SB366791 | 3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺 | 472981-92-3 |
| BV6 | BV 6 | 1001600-56-1 |
| PFI-3 | (2E)-1-(2-羟基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮杂双环[2.2.1]庚-2-基]-2-丙烯-1-酮 | 1819363-80-8 |
| TP-0903 | TP-0903 | 1341200-45-0 |
| 4-Chloro-1-Benzothiophene-2-Carboxylic Acid | 4-氟-1-苯并噻吩-2-羧酸 | 23967-57-9 |
| GW2580 | GW2580 | 870483-87-7 |
| JQ-1 | (S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-基)乙酸叔丁酯 | 1268524-70-4 |
| BMS-5 | BMS-5 | 1338247-35-0 |
| HPI-4,Hedgehog Pathway Inhibitor 4 | HPI-4 | 302803-72-1 |
| MSX-122 | MSX 122 | 897657-95-3 |
| IDO-IN-1 | 4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 | 914638-30-5 |
| SGC707 | N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 | 1687736-54-4 |
| ON123300 | 8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 | 1357470-29-1 |
| Compound 4 | 1-甲苯磺酰-1H-吲哚-2-甲酸乙酯 | 132819-92-2 |
| PD 169316 | 4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶 | 152121-53-4 |
| Cilengitide | 西仑吉肽 | 188968-51-6 |
| ID 8 | 1-(4-甲氧基苯基)-2-甲基-3-硝基-1H-吲哚-6-醇 | 147591-46-6 |
| CGI 1746 | N-[3-[4,5-二氢-4-甲基-6-[[4-(4-吗啉基羰基)苯基]氨基]-5-氧代-2-吡嗪基]-2-甲基苯基]-4-(叔丁基)苯甲酰胺 | 910232-84-7 |
| KN-92 (HCl) | KN-92 盐酸盐 | 1431698-47-3 |
| GZD824 | GZD824 | 1257628-77-5 |
| KN-92 | N-[2-[[[(E)-3-(4-CHLOROPHENYL)PROP-2-ENYL]-METHYLAMINO]METHYL]PHENYL]-4-METHOXYBENZENESULFONAMIDE | 176708-42-2 |
| Atglistatin | ATGLISTATIN | 1469924-27-3 |
| NIBR189 | NIBR189 | 1599432-08-2 |
| BLU9931 | BLU 9931 | 1538604-68-0 |
| PLX8394 | PLX8394 | 1393466-87-9 |
| CP21R7 | GSK-3Β抑制剂(CP21R7) | 125314-13-8 |
| ON1231320 | CS-2589 | 131247-39-8 |
| PD168393 | PD168393 | 194423-15-9 |
| Hoechst33258 | 赫斯特荧光染料 33258 | 23491-45-4 |
| 1-(4-BROMOPHENYL)PIPERAZINE | 1-(4-溴苯基)哌嗪 | 66698-28-0 |
| SB-3CT | SB-3CT | 292605-14-2 |
| Doravirine | 多拉韦林 | 1338225-97-0 |
| CK 1827452 | 4-[[2-氟-3-[N'-(6-甲基吡啶-3-基)脲基]苯基]甲基]哌嗪-1-羧酸甲酯 | 873697-71-3 |
| EPZ004777 | EPZ004777 | 1338466-77-5 |
| RO3280 | RO3280 | 1062243-51-9 |
| U104/NSC 213841/MST104 | U-104 | 178606-66-1 |
| CNX2006 | CNX2006 | 1375465-09-0 |
| UNC0379 | UNC0379 | 1620401-82-2 |
| UNC3866 | UNC3866 | 1872382-47-2 |
| Hoechst33342 | 赫斯特荧光染料 33342 | 23491-52-3 |
| AG 528 | 酪氨酸磷酸化抑制剂AG528 | 133550-49-9 |
联系方式
